Fair Value Calculator Fair Value Calculator
EN DE

1087 (1087) Fair Value & Analysis

Technology · Market cap HK$432M

1 1087 1087 · HK
PriceHK$1.80
Fair ValueHK$0.5300
Upside-70.6%
Quality51/100
Evidence: Low Range HK$0.4000 – HK$0.8000

Fair value as of: Jul 2, 2026

From 1 valuation models · updated today

Share price +157.1% over the past month.

Price vs Fair Value (12 months)

HK$1.87 HK$0.3750 Fair Value HK$0.5300 Jun 2025 Jun 2026

12‑month range HK$0.3750 – HK$1.87 · fair‑value band HK$0.4000 – HK$0.8000 · the HK$1.80 price screens above the HK$0.5300 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

1087 (1087) currently trades at HK$1.80, while our model-based Fair Value estimate is HK$0.5300 — implying the stock looks roughly 70.6% overvalued today. We read business quality at 51/100 (solid quality), in the Technology sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

Over the trailing twelve months, 1087 generated revenue of HK$567M at a net margin of -8.7%. Revenue grew 33.9% year over year. It earns a return on equity of -26.1%. Net debt stands at HK$183M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$567M
Revenue growth (YoY) +33.9%
Net margin -8.7%
Return on equity -26.1%
Free cash flow −HK$63.1M FY2025
Operating margin -1.0%
More key figures
EPS (TTM) HK$-0.0700
Net debt HK$183M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

1087 reported revenue of HK$567M in FY2025 versus HK$485M in FY2021, a compound +4.0%/yr. Reported net income was −HK$49.3M in FY2025.

Revenue +4.0%/yr
FY21 HK$485M
FY22 HK$557M
FY23 HK$561M
FY24 HK$466M
FY25 HK$567M
Net income
FY21 −HK$16.8M
FY22 −HK$35.9M
FY23 −HK$41.2M
FY24 −HK$63.5M
FY25 −HK$49.3M

Is 1087 fairly valued? → Check now

Similar stocks

6 more Communication Equipment stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock Price Fair Value vs Fair Value
Cisco Systems, Inc CSCO $118.80 $43.05 -64%
Foxconn Industrial Internet Co 601138 ¥71.13 ¥25.47 -64%
Zhongji Innolight Co 300308 ¥1,382 ¥223.88 -84%
Eoptolink Technology Inc 300502 ¥579.97 ¥252.67 -56%
Nokia Oyj NOKIA 291.00 CZK 78.99 CZK -73%
Motorola Solutions, Inc MSI $392.23 $190.24 -51%

Explore undervalued stocks

More undervalued Technology stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is 1087 (1087) undervalued?
As of Jul 2, 2026, our model estimates a fair value of HK$0.5300 versus a price of HK$1.80 — about −71% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 1087?
Our model-based fair value for 1087 is HK$0.5300 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$1.80.
What is the quality score of 1087?
1087 has a Quality Score of 51/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of 1087 (1087)?
1087 reported trailing-twelve-month revenue of about HK$567M (latest available figure, as of Jul 2, 2026).
What is the net profit margin of 1087?
The net profit margin of 1087 is about -8.7%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.